Join A Study
The only way we will find a cure for Parkinson’s disease (PD) is through research. Your participation in research is critical to finding new treatments and improving life for the 10 million people living with Parkinson’s around the world.
Explore the different opportunities to get involved with Parkinson’s research.
Parkinson’s Foundation Studies
PD GENEration: Mapping the Future of Parkinson’s Disease
This national initiative offered by the Parkinson’s Foundation provides genetic testing for clinically relevant Parkinson's-related genes and genetic counseling at no cost for people with Parkinson’s. Participation can be either in-person or from home.
Parkinson’s Foundation Surveys
Through this initiative, we aim to advance Parkinson’s care through understanding the experiences of people living with this disease, care partners and healthcare workers —and widely sharing those experiences with the PD community.
Parkinson’s Foundation Collaborative Studies
TOPAZ Trial
People with Parkinson's have a higher risk of fractures. Help us find a solution. Through this NIH-funded study in collaboration with the California Pacific Medical Center Research Institute, the TOPAZ study will test if a medicine called zoledronate can prevent fractures in people with PD. A team of doctors who are experts in bone health and PD are leading the study.
PERSEVERE Study
PERSEVERE is an NIH-funded study in collaboration with Dr. Jori Fleischer at Rush University. This study is testing an educational program for care partners of people with Parkinson’s Disease with cognitive impairment, Parkinson’s Disease Dementia, Dementia with Lewy Bodies, or Lewy Body Dementia. PERSEVERE will test whether a disease-specific, caregiver-centered educational program improves caregiver knowledge, confidence, strain, and health outcomes – and whether it helps people living with Parkinson’s Disease Dementia, Dementia with Lewy Bodies, or Lewy Body Dementia, too.
Parkinson’s Foundation Consortia Member & Related Studies
Consortia members are companies engaged with the Foundation in support of our mission to end PD. Trials listed here are not endorsed by the Parkinson’s Foundation. Read more about our consortia here.
ATLANTIS Study
The ATLANTIS Study, sponsored by the pharmaceutical company UCB, is testing a once-daily oral investigational drug called UCB0022 in people between 35 and 80 who have been diagnosed with Parkinson’s 5 or more years ago and whose motor symptoms change significantly over the course of the day.
Become a Research Advocate
Help us make Parkinson’s research more efficient and effective. Our trained research advocates partner alongside scientists, industry and government on critical PD research studies.
Trials for People with Genetic Links to PD
Explore precision medicine trials designed for people with a confirmed genetic link to Parkinson’s, as tested in the PD GENEration study. PD GENEration currently tests for mutations in seven PD genes: GBA, LRRK2, SNCA, PRKN, PINK1, PARK7 and VPS35.
There are currently no trials recruiting participants with mutations of the following PD-related genes: SNCA, PRKN, PINK1, PARK7 or VPS35.
We will constantly update this list as new trials testing medications for people with genetic forms of PD are announced. If you have information about a new trial, please email Genetics@Parkinson.org.
LEARN MORe about pd generation
ClinicalTrials.gov
ClinicalTrials.gov contains a complete list of PD-related trials. The link below will take you to a listing of interventional trials offered in the US.
Join the Fight Against Parkinson's
Support ground-breaking research, care and community outreach
Related Materials
Related Blog Posts
The Ins and Outs of Participating in Parkinson’s Research
Parkinson’s Foundation Research Advocates Influence Parkinson’s Funding
